The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
How do biotech and pharma sponsors benefit from Accelerator™ Drug Development?
Video
Biotech and biopharma sponsors partnering with Thermo Fisher Scientific through our Accelerator™ Drug Development’s 360° CDMO and CRO solutions gain numerous benefits, including speed, flexibility, and cost savings. From process development to commercial manufacturing, there are opportunities for improvement throughout the drug development journey.
In a recent video, Jennifer Cannon, president of commercial operations, pharma services at Thermo Fisher Scientific, discusses findings from a recent study by the Tufts Center for Drug Development, focusing on oncology. She demonstrates how an integrated CDMO and CRO approach can help reduce clinical drug development timelines by an average of 7-19 months.